Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) Net Margin (2023 - 2024)

Spruce Biosciences has reported Net Margin over the past 2 years, most recently at 3380.06% for Q4 2024.

  • Quarterly Net Margin fell 303695.0% to 3380.06% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 6869.3% through Sep 2025, down 631414.0% year-over-year, with the annual reading at 1079.94% for FY2024, 60550.0% down from the prior year.
  • Net Margin was 3380.06% for Q4 2024 at Spruce Biosciences, down from 1440.37% in the prior quarter.
  • Over five years, Net Margin peaked at 343.1% in Q4 2023 and troughed at 3380.06% in Q4 2024.